Johnson Controls Posts Q4 Adjusted EPS of $1.66, Initiates FY27 Guidance of $6.15-$6.30
JCI sits 38% above its 52-week low of $108.41.
Summary
Johnson Controls closed fiscal 2026 with 10% Q4 sales growth, $1.66 adjusted EPS and a record $23.0 billion backlog, then guided FY27 adjusted EPS to $6.15-$6.30.
Updates
· Benzinga — Johnson Controls shares rose 4.05% to $153.47 after Q4 results and FY27 guidance.
- Q4 Results vs Estimates — Adjusted EPS of $1.66 beat the $1.58 consensus estimate, and revenue of $7.11 billion exceeded the $7.03 billion consensus estimate.
- Profitability — Gross profit rose 15.1% to $2.71 billion, with gross margin of 38.03% versus 36.49%.
- Americas Performance — Americas sales rose 14% to $4.9 billion on 14% organic growth; orders climbed 58% and backlog rose 54% to $17.8 billion, while adjusted segment EBITA margin expanded 210 basis points to 22.0%.
- EMEA Performance — EMEA sales declined 2% to $1.3 billion while organic sales rose 3%; orders rose 12% and backlog grew 18% to $3.1 billion, with adjusted segment EBITA margin up 80 basis points to 16.4%.
- Asia-Pacific Performance — Asia-Pacific sales rose 12% to $871 million on 13% organic growth; orders climbed 11% and backlog increased 12% to $2.1 billion, with adjusted segment EBITA margin up 110 basis points to 18.9%.
- Cash Flow — Quarter-end cash and cash equivalents were $618 million; operating cash flow rose to $1.3 billion from $968 million and free cash flow increased to $1.08 billion from $838 million.
- FY27 Guidance — Q1 FY27 organic sales growth is guided to 12% to 14% and Q1 adjusted EPS to $1.15 to $1.20 per share versus a $1.12 estimate; FY27 adjusted EPS is guided to $6.15 to $6.30 per share versus a $6.16 estimate.
All 18 details
- Adjusted EPS $1.66 beat analyst consensus estimate of $1.58.
- Revenue $7.11 billion exceeded consensus estimate of $7.03 billion.
- Gross profit rose 15.1% to $2.71 billion; gross margin 38.03% vs 36.49%.
- Americas sales rose 14% to $4.9 billion; organic sales up 14%.
- Americas orders climbed 58%; backlog rose 54% to $17.8 billion.
- Americas adjusted segment EBITA margin expanded 210 basis points to 22.0%.
- EMEA sales declined 2% to $1.3 billion; organic sales rose 3%.
- EMEA orders rose 12%; backlog grew 18% to $3.1 billion.
- EMEA adjusted segment EBITA margin improved 80 basis points to 16.4%.
- Asia-Pacific sales rose 12% to $871 million; organic sales up 13%.
- Asia-Pacific orders climbed 11%; backlog increased 12% to $2.1 billion.
- Asia-Pacific adjusted segment EBITA margin expanded 110 basis points to 18.9%.
- Quarter-end cash and cash equivalents were $618 million.
- Operating cash flow rose to $1.3 billion from $968 million a year earlier.
- Free cash flow increased to $1.08 billion from $838 million.
- Q1 FY27 organic sales growth guided to 12% to 14%.
- Q1 adjusted EPS guidance of $1.15 to $1.20 per share compares with analyst estimate of $1.12 per share.
- FY27 adjusted EPS guidance of $6.15 to $6.30 per share compares with analyst estimate of $6.16 per share.
Key Events · Earnings and Guidance · JCI
-
Q4 Sales Up 10%, Adjusted EPS $1.66
Q4 sales of $7.1 billion rose 10% (12% organic); GAAP EPS was $1.60 and adjusted EPS $1.66 versus $1.26 a year ago.
-
Record $23.0 Billion Backlog
Orders rose 44% organically year-over-year and backlog reached $23.0 billion, up 43% organically, driven by data center demand.
-
FY27 Guidance Initiated at $6.15-$6.30
Full-year FY27 adjusted EPS guided to $6.15-$6.30 on 11%-12% organic sales growth and ~95% adjusted free cash flow conversion; Q1 adjusted EPS guided to $1.15-$1.20.
-
Leverage Falls to 1.8x
Net debt of $8.7 billion against $4.7 billion LTM adjusted EBITDA puts net debt to adjusted EBITDA at 1.8x, down from 2.4x a year earlier.
Analysis · JCI · Technology
The headline number is strong, but the real story is the FY27 setup. Q4 sales of $7.1 billion rose 10% (12% organic), adjusted EPS of $1.66 beat the prior-year $1.26, and orders jumped 44% organically with backlog at $23.0 billion, up 43%. Management now guides to 11%-12% organic sales growth and adjusted EPS of $6.15-$6.30 for FY27, with ~95% adjusted free cash flow conversion. Against a $149.90 stock, that guidance implies the market is paying roughly 24x forward adjusted EPS, so execution on the data-center-driven order book is what matters from here. Net debt to adjusted EBITDA fell to 1.8x from 2.4x a year ago, leaving room for the buyback and dividend.
How filings like this one have moved
In the 30 days to Oct 27, 2026, 36.2% of the 898 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.75%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, JCI was trading at $149.90 on NYSE in the Technology sector, with a market capitalization of approximately $89.3B. The 52-week trading range was $108.41 to $160.41. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.